Ramtin Gholizadeh, Faezeh Eslami, Pegah Dejban, Mehdi Ghasemi, Nastaran Rahimi, Ahmad Reza Dehpour
{"title":"Additive Anticonvulsive Effects of Sumatriptan and Morphine on Pentylenetetrazole-Induced Clonic Seizures in Mice.","authors":"Ramtin Gholizadeh, Faezeh Eslami, Pegah Dejban, Mehdi Ghasemi, Nastaran Rahimi, Ahmad Reza Dehpour","doi":"10.14581/jer.24002","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and purpose: </strong>Sumatriptan protects the brain from damage and enhance the anti-seizure effect of morphine. There is evidence that nitric oxide (NO) may mediate these effects of both drugs. In the present study, we investigated the effects of sumatriptan (0.1-20 mg/kg, intraperitoneal [i.p.]) and morphine (0.1-20 mg/kg, i.p.) alone or in combination on seizure thresholds in an <i>in vivo</i> model of seizure in mice. Using various NO synthase inhibitors as well as the NO precursor, we assessed possible involvement of NO signaling in these effects.</p><p><strong>Methods: </strong>Clonic seizures were induced in male Naval Medical Research Institute mice by intravenous administration of pentylenetetrazol (PTZ).</p><p><strong>Results: </strong>Acute sumatriptan administration exerted anti-convulsive effects at 0.5 (<i>p</i><0.01) and 1 mg/kg (<i>p</i><0.05), but pro-convulsive effects at 20 mg/kg (<i>p</i><0.05). Morphine had anti-convulsive effects at 0.5 (<i>p</i><0.05) and 1 mg/kg (<i>p</i><0.001), but exerted pro-convulsive effect at 20 mg/kg (<i>p</i><0.05). Combination treatment with sub-effective doses of sumatriptan (0.1 mg/kg) and morphine (0.1 mg/kg) significantly (<i>p</i><0.05) exerted an anti-convulsive effect. Co-administration of the NO precursor L-arginine (60 mg/kg) with sub-effective doses of sumatriptan and morphine significantly (<i>p</i><0.05) increased seizure threshold compared with sumatriptan alone, but not sumatriptan+morphine group. While concomitant administration of either the non-selective NO synthase (NOS) inhibitor L-N<sup>G</sup>-nitroarginine methyl ester (5 mg/kg) or the selective inducible NOS inhibitor aminoguanidine (50 mg/kg) with combined sub-effective doses of morphine and sumatriptan produced significant anticonvulsive effects, concomitant administration with the selective neuronal NOS inhibitor 7-nitroindazole (30 mg/kg) inhibited this effect.</p><p><strong>Conclusions: </strong>Our data suggest a possible role for the NO signaling in the anticonvulsive effects of combined sumatriptan and morphine on the PTZ-induced clonic seizures in mice.</p>","PeriodicalId":73741,"journal":{"name":"Journal of epilepsy research","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11227926/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of epilepsy research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14581/jer.24002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background and purpose: Sumatriptan protects the brain from damage and enhance the anti-seizure effect of morphine. There is evidence that nitric oxide (NO) may mediate these effects of both drugs. In the present study, we investigated the effects of sumatriptan (0.1-20 mg/kg, intraperitoneal [i.p.]) and morphine (0.1-20 mg/kg, i.p.) alone or in combination on seizure thresholds in an in vivo model of seizure in mice. Using various NO synthase inhibitors as well as the NO precursor, we assessed possible involvement of NO signaling in these effects.
Methods: Clonic seizures were induced in male Naval Medical Research Institute mice by intravenous administration of pentylenetetrazol (PTZ).
Results: Acute sumatriptan administration exerted anti-convulsive effects at 0.5 (p<0.01) and 1 mg/kg (p<0.05), but pro-convulsive effects at 20 mg/kg (p<0.05). Morphine had anti-convulsive effects at 0.5 (p<0.05) and 1 mg/kg (p<0.001), but exerted pro-convulsive effect at 20 mg/kg (p<0.05). Combination treatment with sub-effective doses of sumatriptan (0.1 mg/kg) and morphine (0.1 mg/kg) significantly (p<0.05) exerted an anti-convulsive effect. Co-administration of the NO precursor L-arginine (60 mg/kg) with sub-effective doses of sumatriptan and morphine significantly (p<0.05) increased seizure threshold compared with sumatriptan alone, but not sumatriptan+morphine group. While concomitant administration of either the non-selective NO synthase (NOS) inhibitor L-NG-nitroarginine methyl ester (5 mg/kg) or the selective inducible NOS inhibitor aminoguanidine (50 mg/kg) with combined sub-effective doses of morphine and sumatriptan produced significant anticonvulsive effects, concomitant administration with the selective neuronal NOS inhibitor 7-nitroindazole (30 mg/kg) inhibited this effect.
Conclusions: Our data suggest a possible role for the NO signaling in the anticonvulsive effects of combined sumatriptan and morphine on the PTZ-induced clonic seizures in mice.
背景和目的:舒马普坦能保护大脑免受损伤,并增强吗啡的抗癫痫作用。有证据表明,一氧化氮(NO)可能介导了这两种药物的上述作用。在本研究中,我们在小鼠体内癫痫发作模型中研究了舒马曲坦(0.1-20 毫克/千克,腹腔注射[i.p.])和吗啡(0.1-20 毫克/千克,i.p.)单独或联合使用对癫痫发作阈值的影响。通过使用各种 NO 合酶抑制剂以及 NO 前体,我们评估了 NO 信号转导在这些效应中可能的参与作用:方法:通过静脉注射戊四唑(PTZ)诱导雄性海军医学研究所小鼠阵挛性癫痫发作:结果:急性舒马曲普坦给药在0.5(pppppppG-硝基精氨酸甲酯(5毫克/千克)或选择性诱导性NOS抑制剂氨基胍(50毫克/千克)与亚有效剂量吗啡和舒马曲普坦联合给药产生了显著的抗惊厥作用,同时给药选择性神经元NOS抑制剂7-硝基吲唑(30毫克/千克)抑制了这种作用:我们的数据表明,NO 信号在舒马曲坦和吗啡联合使用对 PTZ 诱导的小鼠阵挛性癫痫发作的抗惊厥作用中可能发挥作用。